Kyiv Regional Oncological Dispensary
About Kyiv Regional Oncological Dispensary
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
6
Bayer
1
Janssen Research & Development, LLC
1
Clinical Trials at Kyiv Regional Oncological Dispensary
During the past decade, Kyiv Regional Oncological Dispensary conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on
average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Participants
2014-08-19
2026-09-29
Active, not recruiting
303
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
2018-08-02
2025-08-24
Active, not recruiting
2,300
A Study Of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer.
2019-11-25
2023-02-28
Completed
242
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer)
2020-09-04
2021-11-24
Completed
221
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
2020-09-23
2027-05-07
Recruiting
692
A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)
2020-11-27
2023-11-27
Active, not recruiting
303
Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer
2021-02-23
2025-09-26
Active, not recruiting
662
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)
2021-08-27
2033-11-21
Recruiting
4,100
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Kyiv Regional Oncological Dispensary"
#1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator, "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator and "Orion Corporation, Orion Pharma" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Kyiv Regional Oncological Dispensary
According to Clinical.Site data, the most researched conditions in "Kyiv Regional Oncological Dispensary" are
"Early Breast Cancer" (2 trials), "Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer" (1 trials), "Metastatic Castrate Sensitive Prostate Cancer" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Prostatic Neoplasms" (1 trials). Many other conditions were trialed in "Kyiv Regional Oncological Dispensary" in a lesser frequency.
Clinical Trials Intervention Types at Kyiv Regional Oncological Dispensary
Most popular intervention types in "Kyiv Regional Oncological Dispensary" are "Drug" (8 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Giredestrant" (3 trials), "Atezolizumab" (2 trials), "LHRH Agonist" (2 trials), "Paclitaxel" (2 trials) and "Abiraterone acetate (AA)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kyiv Regional Oncological Dispensary
The vast majority of trials in "Kyiv Regional Oncological Dispensary" are
5 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.
Clinical Trials Status at Kyiv Regional Oncological Dispensary
Currently, there are NaN active trials in "Kyiv Regional Oncological Dispensary".
undefined are not yet recruiting,
2 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Kyiv Regional Oncological Dispensary,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kyiv Regional Oncological Dispensary, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".